We are conducting a study on canine mast cell tumors to evaluate their cells and their response to specific chemotherapy drugs.
Currently Enrolling (Last Update: March 2023)
ImpriMed is seeking clinical research partners to collect live cancer cells from canine mast cell tumors. At this time, we are not providing any reports or predictions to our participating research partners. CBC and blood chemistry data are available upon request.
We are requesting the samples from:
Canine patients with suspected mast cell tumors
For each patient, we request all of the following:
If you have not already, please register for access to our Vet Portal by clicking HERE. At the top of the page, hover over ‘Samples’ -> Select ‘MCT Pilot Study’ from the drop-down.
Please ensure all participating pet owners sign the consent form to allow us to use their dog’s sample for research.
One of the many benefits of AI-led diagnostics like ImpriMed is the ability to be constantly developing and improving based on the clinical outcomes of existing cases. This approach to the evolution of the assay improves the accuracy and applicability for all returning and future patients.
We will be reaching out to all clients 3-5 months after sampling to request data on which treatment courses were ultimately used and how the patient responded to compare how closely the predictions aligned with the clinical outcomes.
To get started, fill out the form and we will send you our proprietary transport media tubes to your clinic.